History of stroke 512 (1.2) 3544 (4.8 ) History of failure 824 (2.0) (16.0) History of PAD, % 491 (1.2) 5159 (7.0 ) History of CKD 2,577 (6.1) (25.1) N/A 2324 (3.2 ) History of dementia, % Charlson index 26,181 (62.1) 15948 (21.7) 0 1-3 13,193 (31.3) (35.5) 4 2,764 (6.6) 31471 (42.8) ≥ Depression, % 2,876 (6.8) 9733 (13.2) Hospitalization in year to MI 3,993 (9.5) 18971 (25.8) Cardiologist care 10,505 (24.9) 26317 (35.8) Use of non-statin lipid-lowering 8852 (12.0) 3,457 (8.2) therapy Total number of medications taken <5 19,683 (46.7) 14986 (20.4) 5 9 12,318 (29.2) 20775 (28.3) – 10 10,137 (24.1) 37740 (51.3) ≥ Data from the 30 days post-discharge Beta-blocker fill, % 37,350 (88.6) 60592 (82.4) Antiplatelet agent fill, % 34,145 (81.0) 49628 (67.5) Non-statin lipid-lowering therapy 4568 (6.2 ) 2,334 (5.5) fill, % Cardiac rehabilitation, % 6,971 (16.5) (14.7) Abbreviations: CHD, coronary heart disease; CKD, chronic kidney disease; MI, myocardial infarction; PAD, peripheral arterial disease.
History of stroke 512 (1.2) 3544 (4.8 ) History of failure 824 (2.0) (16.0) History of PAD, % 491 (1.2) 5159 (7.0 ) History of CKD 2,577 (6.1) (25.1) History of dementia, % N/A 2324 (3.2 ) Charlson index 0 26,181 (62.1) 15948 (21.7) 1-3 13,193 (31.3) (35.5) ≥ 4 2,764 (6.6) 31471 (42.8) Depression, % 2,876 (6.8) 9733 (13.2) Hospitalization in year to MI 3,993 (9.5) 18971 (25.8) Cardiologist care 10,505 (24.9) 26317 (35.8) Use of non-statin lipid-lowering therapy 3,457 (8.2) 8852 (12.0) Total number of medications taken <5 19,683 (46.7) 14986 (20.4) 5 – 9 12,318 (29.2) 20775 (28.3) ≥ 10 10,137 (24.1) 37740 (51.3) Data from the 30 days post-discharge Beta-blocker fill, % 37,350 (88.6) 60592 (82.4) Antiplatelet agent fill, % 34,145 (81.0) 49628 (67.5) Non-statin lipid-lowering therapy fill, % 2,334 (5.5) 4568 (6.2 ) Cardiac rehabilitation, % 6,971 (16.5) (14.7) Abbreviations: CHD, coronary heart disease; CKD, chronic kidney disease; MI, myocardial infarction; PAD, peripheral arterial disease.